Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Clinical trial NCT06452602 · RECRUITING
Trial details
- NCT number
- NCT06452602
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2026-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.